(617) 551-8111
300 THIRD STREET, 3RD FLOOR
Cambridge, MA 02142-1103
alnylam pharmaceuticals, a leader in rnai therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as rna interference (rnai).
In Business Since: | 2002 |
Business Sector: | Residential, Commercial |
ALNYLAM PHARMACEUTICALS INC | Biotherapeutics | New Pre-Clinical Data... | RNAi Clinical Trials | Delivery Strategies for... | Media Kit | Silencing of Lipid Metabolism... | About RNAi | Programs & Pipeline | About Alnylam | InterfeRx and Reagent Licenses | Advantages of RNAi | Illustrations of RNAi... | conjugate | New Ventures | Product Platform | Biodegradable Lipids... | View All | pre-clinical | Delivery